News
Speaking at Carnegie Mellon University earlier this month, Trump outlined his program of reorganizing the American economy in ...
If you’re looking for the best online economics degrees, check out our top 10 ranking, list of economics degree jobs and more.
Summit Therapeutics has revealed that a second pivotal trial of its Akeso-partnered PD-1xVEGF bispecific ivonescimab has failed to show an improvement in overall survival in a lung cancer trial.
Shares in Summit Therapeutics have risen sharply on a report that AstraZeneca is in discussions for a partnership focused on PD-1xVEGF bispecific ivonescimab that is estimated to be worth as much ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results